Dundee is the location of one of the UK's most exciting and dynamic biomedical and life sciences communities in the UK. With world-class companies, universities, research institutes and scientists all operating within a three mile radius. Dundee offers a wide range of expertise from drug discovery, through medical devices and diagnostics, to ag-biotech and environmental biotechnology.
Home to one of the largest teaching hospitals in Europe (Ninewells Hospital & Medical School) and 3 world renowned Universities all within a 14 mile radius: University of Dundee, Abertay University and the University of St Andrews.
The close collaboration between the University of Dundee and NHS Tayside creates an environment to stimulate innovation to drive health and social care improvement. One of the most important goals is to further develop and maintain an “environment where industry finds it easy to establish collaborative partnerships with both the University and NHS Tayside”.
The University of Dundee is one of the leading universities in Europe for research in Life Sciences. More recent rankings widely recognized as indicators of scientific excellence place Dundee high in their rankings. The 2020 QS World University Rankings in Biological Sciences place Dundee joint 1st in the UK and Europe and joint 16th in the World as judged by ‘citations-per-paper’, one of the most widely recognized metrics of scientific excellence. ‘The State of Innovation’ report by Clarivate Analytics ranks Dundee as the most influential scientific research institution in the world for pharmaceuticals for the period 2006-16. The School enjoys a reputation as one of the most dynamic international centres for molecular cell biology, with outstanding laboratory and technology facilities.
The University of Dundee Drug Discovery Unit is a fully operational, fully integrated drug discovery group working across multiple disease areas collaborating with partners to translate world-class biology research into novel drug targets and candidate drugs to address unmet medical need across our two areas of activity, Diseases of the Developing World and Innovative Targets Portfolio. Building on success in these areas they are also developing an Antibacterial Drug Discovery Accelerator.
The James Hutton Institute is a well-respected and globally recognised research organisation delivering fundamental and applied science to drive the sustainable use of land and natural resources.
The Institute for Medical Science and Technology (IMSaT), founded in 2006, uses Interface Science research, defined as research at the interface of the Life and the Physical Sciences and Engineering. The theme(s)-based research is carried out by interdisciplinary groups (medics, life scientists, biologists physicists, material scientists, interventional radiologists/ MRI, surgical technologists, and robotic engineers) working in shared laboratories. The interface science R&D paradigm has the benefit of accelerating development and clinical translation from Lab- to-clinic of new technologies for improved diagnosis and treatment of life-threating disorders.